OpenEvidence vs PubMed: which one should you use to research your own health?

If you have ever tried to check what the research actually says about a supplement, a symptom, or a drug interaction, you have probably bumped into both of these names. PubMed is the vast public index of the medical literature — the place the papers live. OpenEvidence is the newer AI answer engine that reads across those papers and hands you a synthesised, referenced answer. People treat them as rivals. They are closer to two stations on the same line.

The confusion matters because using the wrong one for the wrong moment wastes the thing you have least of: attention. Reach for PubMed when you want an AI-shaped verdict and you drown in abstracts. Reach for OpenEvidence when you needed to see the raw spread of studies and you get a confident paragraph that skips the mess. This is a guide to telling them apart — and to using both without letting either one think for you.

what each one actually is

PubMed is a search engine over more than 35 million citations from biomedical literature — journals, life-science books, the lot. It is maintained by the US National Library of Medicine and it is genuinely free, no account required. What it gives you is the citation and abstract, and, where available, a link out to the full text. It does not summarise, it does not conclude, and it does not care whether you understood what you read. It is a library, and it behaves like one.

OpenEvidence sits one layer up. It is an AI system built for the point of care — its natural user is a clinician with a question between patients — and it answers in that register: a synthesised, referenced response that reads like a specialist who has already done the reading. Ask it something specific and clinical and you get a paragraph of reasoning with citations threaded through it, drawn from medical journals and clinical sources rather than the open web.

“PubMed shows you the shelf. OpenEvidence reads a stretch of the shelf and writes you a note. Most health mistakes come from wanting the note but only having time for the shelf — or trusting the note without ever checking the shelf.”

is OpenEvidence free?

Mostly, yes — with an asterisk. OpenEvidence has been free to use for verified healthcare professionals, funded on the back end rather than by a subscription at the point of use. That is a very different model from PubMed, which is free because it is public infrastructure paid for by a national library. The practical upshot for a non-clinician: PubMed is unconditionally open to you, while OpenEvidence was designed around clinician verification and its access terms can change as the product and its funding evolve.

So if you are a thoughtful person researching your own body rather than a doctor, PubMed is the tool you can always count on being able to open. Treat any access you have to a clinician-facing engine as a bonus, not a foundation — and never let a paywall or a login gate become the reason you skip reading the actual source.

how accurate is OpenEvidence?

This is the question that matters, and the honest answer is: accurate enough to be genuinely useful, and confident enough to be genuinely dangerous if you switch your brain off. Because it is grounded in the published literature and cites as it goes, OpenEvidence avoids much of the free-floating invention that makes a general chatbot risky for health questions. But ‘grounded in citations’ is not the same as ‘correct for you.’

An AI synthesis can lean on a small or dated study, can smooth over genuine disagreement in the field into one tidy conclusion, and can answer the average case when your case is not average. It is also only as good as the question you asked and the population the underlying studies looked at. The tool has done the reading — but it has done the reading for a generic patient, not for your age, your meds, your history.

how they handle citations

Both tools point you at real papers, but they cite for different readers, and that changes what your job is.

• PubMed IS the citation — there is no synthesis to check, only sources to read. The work is entirely yours: build the search, scan the abstracts, judge the quality, form the view. Slow, but nothing is hidden from you.
• OpenEvidence threads references into a finished answer — the value is the reasoning, and the citations back it up. Faster, but the tool has already made the call, so your job shifts to auditing whether the call was fair.

The rule that protects you is the same for both: a claim you cannot trace to a source you can open is not evidence yet, it is a rumour with good posture. Whichever tool you use, the citation is not decoration. It is the part you actually verify.

peer review, and what ‘evidence’ hides

Both tools lean on published, peer-reviewed research, which is exactly why people reach for them instead of a general chatbot. But ‘it’s in a study’ is the beginning of the work, not the end of it. A single small trial and a large meta-analysis are both ‘evidence,’ and they carry wildly different weight. This is where our own evidence hierarchy does the heavy lifting: systematic reviews and large randomised trials near the top; single studies, animal work and mechanistic reasoning much further down.

PubMed shows you the raw spread but leaves the weighting entirely to you. OpenEvidence does some of the weighting for you, which is faster but asks you to trust the synthesis. Neither one removes your job: to notice study size, population, and whether the paper actually studied people like you. A great deal of health research was never about the person reading it.

which one for the non-clinical reader

If you are not a clinician — you are someone trying to understand your own body — here is the honest split. PubMed is the tool you will always be able to open, and it rewards patience: it is the ground truth, and learning to run a decent search on it is one of the highest-return literacy skills you can build. OpenEvidence, when you can use it, is a spectacular accelerator — but it speaks fluent clinician, and its answers assume a reader who can weigh a contraindication without flinching.

That does not make either one off-limits. It makes PubMed your foundation and OpenEvidence the fast draft you always check against that foundation. The mistake is treating either output as instructions. A referenced answer about a treatment is context to bring to the person who can actually prescribe it, not a prescription you write yourself.

how to stack both in the Research Layer

The point of the Research Layer was never to crown one tool. It is to have a repeatable way to turn a worry into a well-founded question. Here is the sequence that uses each tool for what it’s best at.

1. If you have access, start with OpenEvidence for a fast, cited draft of what the evidence says. Read it as a hypothesis, not a verdict — you are getting oriented, not deciding.
2. Take the specific claim that matters most and go straight to PubMed. Search the actual term, filter for reviews and larger trials, and read the abstracts yourself.
3. Open at least two full papers. Check the population and the size. This is the step that separates being informed from being impressed.
4. Write down what you found in your own words, in a place you own — the Ledger. One line: what the evidence says, how strong it is, what you’re still unsure about.
5. Take the unresolved part to a qualified human. The tools got you a better question; the clinician gets you the decision. That hand-off is the design, not a failure of it.

“The stack is not OpenEvidence or PubMed. It is OpenEvidence to draft, PubMed to verify, your own reading to weigh, and a human to decide. Any single tool doing all four is how people end up confidently wrong.”

the part no tool can do

Both of these tools are genuinely good, and the AI layer is getting better faster than anything you could have used five years ago. That is exactly why the skill worth building is not ‘which one has the best answers’ but ‘how do I read any of them well.’ The interfaces will keep changing names and access terms. The literacy — weighing a study, tracing a citation, knowing where your question stops and a clinician’s begins — is the part that stays yours and keeps its value no matter which engine is winning this quarter.

So use both. Let OpenEvidence give you the fast, cited draft and let PubMed keep it honest. Then close the laptop, keep the finding somewhere you can read it later, and remember that the most valuable tool in the Research Layer was never the search engine. It was the reader who knows what to do with what it finds.